Elevance Health, Inc.'s (NYSE:ELV) Stock Has Fared Decently: Is the Market Following Strong Financials?
Elevance Health, Inc.'s (NYSE:ELV) Stock Has Fared Decently: Is the Market Following Strong Financials?
Elevance Health's (NYSE:ELV) stock up by 3.9% over the past three months. Given its impressive performance, we decided to study the company's key financial indicators as a company's long-term fundamentals usually dictate market outcomes. Particularly, we will be paying attention to Elevance Health's ROE today.
Elevance Health（纽约证券交易所代码：ELV）的股票在过去三个月中上涨了3.9％。鉴于其令人印象深刻的业绩，我们决定研究公司的关键财务指标，因为公司的长期基本面通常决定着市场业绩。特别是，我们今天将关注Elevance Health的投资回报率。
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.
投资回报率或股本回报率是评估公司如何有效地从股东那里获得投资回报的有用工具。简而言之，投资回报率显示了每美元从其股东投资中产生的利润。
View our latest analysis for Elevance Health
查看我们对 Elevance Health 的最新分析
How To Calculate Return On Equity?
如何计算股本回报率？
Return on equity can be calculated by using the formula:
股本回报率可以通过使用以下公式计算：
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
股本回报率 = 净利润（来自持续经营业务）÷ 股东权益
So, based on the above formula, the ROE for Elevance Health is:
因此，根据上述公式，Elevance Health 的 ROE 为：
17% = US$6.5b ÷ US$38b (Based on the trailing twelve months to June 2023).
17% = 65亿美元 ⇒ 380亿美元（基于截至2023年6月的过去十二个月）。
The 'return' refers to a company's earnings over the last year. One way to conceptualize this is that for each $1 of shareholders' capital it has, the company made $0.17 in profit.
“回报” 是指公司去年的收益。将其概念化的一种方法是，公司每拥有1美元的股东资本，就会获得0.17美元的利润。
What Is The Relationship Between ROE And Earnings Growth?
投资回报率与收益增长之间有什么关系？
So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.
到目前为止，我们已经了解到，投资回报率是衡量公司盈利能力的指标。现在，我们需要评估公司再投资或 “保留” 了多少利润以用于未来的增长，从而使我们对公司的增长潜力有所了解。一般而言，在其他条件相同的情况下，股本回报率和利润留存率高的公司的增长率要高于不具有这些属性的公司。
Elevance Health's Earnings Growth And 17% ROE
Elevance Health的收益增长和17％的投资回报率
At first glance, Elevance Health seems to have a decent ROE. On comparing with the average industry ROE of 11% the company's ROE looks pretty remarkable. Probably as a result of this, Elevance Health was able to see a decent growth of 9.6% over the last five years.
乍一看，Elevance Health 的投资回报率似乎不错。与11％的行业平均投资回报率相比，该公司的投资回报率看起来非常出色。可能是由于这个原因，Elevance Health在过去五年中实现了9.6％的可观增长。
Next, on comparing Elevance Health's net income growth with the industry, we found that the company's reported growth is similar to the industry average growth rate of 11% over the last few years.
接下来，在将Elevance Health的净收入增长与该行业进行比较时，我们发现该公司报告的增长与过去几年11％的行业平均增长率相似。
Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is Elevance Health fairly valued compared to other companies? These 3 valuation measures might help you decide.
收益增长是股票估值的重要因素。投资者应尝试确定收益的预期增长或下降（无论情况如何）是否被计入其中。通过这样做，他们将知道该种群是要进入清澈的蓝色海水，还是沼泽水域在等待。与其他公司相比，Elevance Health 的估值是否公平？这三种估值衡量标准可能会帮助您做出决定。
Is Elevance Health Making Efficient Use Of Its Profits?
Elevance Health 是否在有效利用其利润？
In Elevance Health's case, its respectable earnings growth can probably be explained by its low three-year median payout ratio of 19% (or a retention ratio of 81%), which suggests that the company is investing most of its profits to grow its business.
就Elevance Health而言，其可观的收益增长可以用其较低的三年中位派息率为19％（或81％的留存率）来解释，这表明该公司正在将其大部分利润投资于业务增长。
Besides, Elevance Health has been paying dividends for at least ten years or more. This shows that the company is committed to sharing profits with its shareholders. Our latest analyst data shows that the future payout ratio of the company over the next three years is expected to be approximately 16%. Accordingly, forecasts suggest that Elevance Health's future ROE will be 15% which is again, similar to the current ROE.
此外，Elevance Health支付股息已有至少十年或更长时间了。这表明该公司致力于与股东分享利润。我们最新的分析师数据显示，该公司未来三年的派息率预计约为16％。因此，预测表明，Elevance Health未来的投资回报率将为15％，这与目前的投资回报率相同。
Summary
摘要
On the whole, we feel that Elevance Health's performance has been quite good. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings are expected to accelerate. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company.
总体而言，我们觉得 Elevance Health 的表现相当不错。特别是，很高兴看到该公司对其业务进行了大量投资，而且回报率很高，这使其收益有了可观的增长。话虽如此，最新的行业分析师预测显示，该公司的收益预计将加速。这些分析师的预期是基于对该行业的广泛预期，还是基于公司的基本面？点击此处进入我们分析师对公司的预测页面。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗？担心内容吗？ 取得联系 直接和我们在一起。 或者，给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。 我们仅使用公正的方法根据历史数据和分析师的预测提供评论，我们的文章无意作为财务建议。 它不构成买入或卖出任何股票的建议，也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意，我们的分析可能不考虑最新的价格敏感公司公告或定性材料。简而言之，华尔街在上述任何股票中都没有头寸。